A preclinical model developed at UT Southwestern Medical Center that recapitulates a rare infant-onset form of diabetes ...

Pancreatic cancer is on the rise in the United States, but there's another, less common type called pancreatic neuroendocrine ...

Get Instant Summarized Text (Gist) A new diabetes treatment platform has been developed using bioink from pancreatic tissue and 3D bioprinting. This platform, called HICA-V, arranges stem cell ...

The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic ...

The most common pathology affecting the pancreas is excess intra ... the islets of Langerhans on the endocrine side. Additionally, when functional pancreatic cells die, particularly acinar cells ...

An innovative platform replicates pancreatic functions, transforming diabetes therapy. A research team led by Professor Jinah Jang from the Departments of Mechanical Engineering, Life Sciences, IT ...

With strong progression-free survival benefits demonstrated in the CABINET trial and updates to National Comprehensive Cancer ...

A research team led by Professor Jinah Jang from the Departments of Mechanical Engineering, Life Sciences, IT Convergence Engineering, and the Graduate School of Convergence Science and Technology ...

The US Food and Drug Administration (FDA) has approved Exelixis’ Cabometyx (cabozantinib) to treat advanced neuroendocrine ...